FCBT
SCMP

First Citizens Bank & Trust’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

First Citizens Bank & Trust’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,093
Closed -$116K – 469
2017
Q2 		$116K Buy
+11,093
New +$113K 0.01% 424

Other funds holding SCMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

First Citizens Bank & Trust's SCMP Position: Q3 2017 in Review

First Citizens Bank & Trust sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2017, closing a stake of 11,093 shares — an estimated $116K sold.

First Citizens Bank & Trust first reported a position in SCMP in Q2 2017 and held it in 1 quarter. The position peaked at $116K in Q2 2017. 178 funds tracked by Wall St. Rank hold SCMP as of Q3 2017.

  • First Citizens Bank & Trust reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • First Citizens Bank & Trust sold 11,093 Sucampo Pharmaceuticals, Inc. shares in Q3 2017, an estimated $116K.
  • First Citizens Bank & Trust first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2017 and held it in 1 quarter.
  • First Citizens Bank & Trust's Sucampo Pharmaceuticals, Inc. position peaked at $116K in Q2 2017.
  • 178 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2017.

Based on First Citizens Bank & Trust's 13F filing for Q3 2017, filed 12 Oct 2017.